What is the measuring device that accelerated the research on direct reprogramming technology in regenerative medicine, which is highly anticipated?

Regenerative medicine is expected to become a treatment for diseases with high unmet medical needs. Among these, direct reprogramming technology can induce target cells from somatic cells without the use of pluripotent stem cells, potentially reducing both time and economic costs compared to conventional techniques. We spoke with Associate Professor Hideki Endo from Juntendo University Graduate School of Medicine, who is advancing research aimed at establishing regenerative treatment for type 1 diabetes patients through direct reprogramming, about this technology and the fully automated immunoassay system that has been key to its progress. Excerpt from the interview article: "If many researchers recognize that it can be used instead of conventional ELISA, and that it is simple and speedy, it could be utilized not only in regenerative medicine but also in other fields, leading to overall advancements in research." *The full text can be downloaded and viewed by clicking the "Download Catalog" button for the user interview article. For more details, please feel free to contact us.

basic information

Price range

Delivery Time

Applications/Examples of results